<?xml version="1.0" encoding="UTF-8"?>
<ref id="B132-jcm-09-01917">
 <label>132.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Song</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zuo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Huo</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>The efficacy of Chinese patent medicine combined with entecavir for the treatment of chronic HBV-related liver fibrosis or cirrhosis: Protocol for a systematic review and meta-analysis of randomized controlled trials or prospective cohort studies</article-title>
  <source>Medicine (Baltimore)</source>
  <year>2019</year>
  <volume>98</volume>
  <fpage>e15732</fpage>
  <pub-id pub-id-type="doi">10.1097/MD.0000000000015732</pub-id>
  <?supplied-pmid 31145288?>
  <pub-id pub-id-type="pmid">31145288</pub-id>
 </element-citation>
</ref>
